Creo Medical’s Speedboat RS2 and CROMA FDA Cleared for Endoscopic Submucosal Dissection

Creo Medical Group out of Chepstow in South Wales won clearance from the FDA for its Speedboat RS2 device and CROMA platform for endoscopic removal of cancerous and pre-cancerous lesions in the bowel. This was one of the fastest FDA reviews of a 510(k) cleared medical device to date, with the company receiving the answer 49 days following submissi (Read more...)

Full Story →